Review Article: Advancing Cancer Treatment With Mesoporous Silica Nanoparticle-Based Theranostics
Abstract
Cancer is a major cause of death globally. It is often detected at a late stage, while
conventional treatments are more effective during the early and middle stages.
These traditional treatments also cause many side effects due to the lack of
targeted delivery. Nanotechnology, particularly mesoporous silica nanoparticles
(MSNs), has been investigated for cancer treatment and diagnosis. Theranostics,
which combine therapy and diagnostics, can provide simultaneous treatment and
detection, potentially lowering mortality rates. A literature review was conducted
using keywords such as mesoporous silica nanoparticles, cancer, diagnosis, and
therapy in online databases like PubMed. The results of this review were analyzed
and compared with existing literature, aiming to provide a comprehensive
overview of mesoporous silica nanoparticles as current cancer treatment and
diagnosis.
Keywords: MSNs, cancer, theranostic, therapy, literature.
Full Text:
PDFReferences
International Agency for Research on Cancer. Statistics at a glance, 2022 Top 5 most frequent cancers Number of new cases 408 661 Number of deaths 242 988 Number of prevalent cases (5-year) [Internet]. 2024 [cited 2024 Jul 4]. Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/360-indonesia-fact-sheet.pdf
Brown JS, Amend SR, Austin RH, Gatenby RA, Hammarlund EU, Pienta KJ. Updating the Definition of Cancer. Molecular Cancer Research. 2023;21(11):1142–7.
Nazarian R, Jazirehi AR. Epigenomics and Targeted Therapy in Cancer. Epigenomics. 2014 Dec;6(6):571–5.
Shah J V., Gonda A, Pemmaraju R, Subash A, Bobadilla Mendez C, Berger M, et al. Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring. Front Mol Biosci. 2020 Oct 6;7.
Qu Z. Investigating Conventional and Novel Methods for Treatment of Cancer. In: ACM International Conference Proceeding Series. Association for Computing Machinery; 2023. p. 103–11.
Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: Progress, challenges and opportunities. Vol. 17, Nature Reviews Cancer. Nature Publishing Group; 2017. p. 20–37.
Wang Y, Huang L. Composite Nanoparticles for Gene Delivery. Adv Genet. 2014 Jan 1;88:111–37.
Paul S, Hmar EBL, Pathak H, Sharma HK. An overview on nanocarriers. Nanocarriers for Drug-Targeting Brain Tumors. 2022 Jan 1;145–204.
Igaz N, Bélteky P, Kovács D, Papp C, Rónavári A, Szabó D, et al. Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells. Int J Nanomedicine. 2022;17:3079–96.
Vaz-Ramos J, Cordeiro R, Castro MMCA, Geraldes CFGC, Costa BFO, Faneca H, et al. Supercritically dried superparamagnetic mesoporous silica nanoparticles for cancer theranostics. Materials Science and Engineering C. 2020 Oct 1;115.
Saroj S, Rajput SJ. Composite smart mesoporous silica nanoparticles as promising therapeutic and diagnostic candidates: Recent trends and applications. Vol. 44, Journal of Drug Delivery Science and Technology. Editions de Sante; 2018. p. 349–65.
Attia MS, Abdel-Mottaleb MSA, Mohamed EH. Smart nanovesicles for drug delivery. Systems of Nanovesicular Drug Delivery. 2022 Jan 1;367–85.
Saroj S, Rajput SJ. Etoposide encapsulated functionalized mesoporous silica nanoparticles: Synthesis, characterization and effect of functionalization on dissolution kinetics in simulated and biorelevant media. J Drug Deliv Sci Technol. 2018 Apr 1;44:27–40.
Esfahani MKM, Islam N, Cabot PJ, Izake EL. Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy. ACS Biomater Sci Eng. 2022 Oct 10;8(10):4153–62.
Wang D, Yu D, Liu X, Wang Q, Chen X, Hu X, et al. Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticles. Technol Cancer Res Treat. 2020;19.
Freidus LG, Kumar P, Marimuthu T, Pradeep P, Choonara YE. Theranostic Mesoporous Silica Nanoparticles Loaded With a Curcumin-Naphthoquinone Conjugate for Potential Cancer Intervention. Front Mol Biosci. 2021 May 20;8.
Torabi M, Aghanejad A, Savadi P, Barzegari A, Omidi Y, Barar J. Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells. BioImpacts. 2023 May 1;13(3):255–67.
Edalatian Tavakoli S, Motavalizadehkakhky A, Homayouni Tabrizi M, Mehrzad J, Zhiani R. Study of the anti-cancer activity of a mesoporous silica nanoparticle surface coated with polydopamine loaded with umbelliprenin. Sci Rep. 2024 Dec 1;14(1).
He L, Habibovic P, van Rijt S. Selenium-incorporated mesoporous silica nanoparticles for osteosarcoma therapy. Biomater Sci. 2023 Apr 19;11(11):3828–39.
Abouaitah K, Hassan HA, Swiderska-Sroda A, Gohar L, Shaker OG, Wojnarowicz J, et al. Targeted nano-drug delivery of colchicine against colon cancer cells by means of mesoporous silica nanoparticles. Cancers (Basel). 2020 Jan 1;12(1).
Laranjeira MS, Ribeiro TP, Magalhães AI, Silva PC, Santos JAM, Monteiro FJ. Magnetic mesoporous silica nanoparticles as a theranostic approach for breast cancer: Loading and release of the poorly soluble drug exemestane. Int J Pharm. 2022 May 10;619.
Ghobadi M, Salehi S, Ardestani MTS, Mousavi-Khattat M, Shakeran Z, Khosravi A, et al. Amine-functionalized mesoporous silica nanoparticles decorated by silver nanoparticles for delivery of doxorubicin in breast and cervical cancer cells. European Journal of Pharmaceutics and Biopharmaceutics. 2024 Jun;114349.
Du D, Fu HJ, Ren W wei, Li XL, Guo LH. PSA targeted dual-modality manganese oxide–mesoporous silica nanoparticles for prostate cancer imaging. Biomedicine and Pharmacotherapy. 2020 Jan 1;121.
Garrido-Cano I, Adam-Artigues A, Lameirinhas A, Blandez JF, Candela-Noguera V, Lluch A, et al. Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy. ACS Appl Mater Interfaces. 2023 Aug 16;15(32):38323–34.
Mohebian Z, Babazadeh M, Zarghami N. In Vitro Efficacy of Curcumin-Loaded Amine-Functionalized Mesoporous Silica Nanoparticles against MCF-7 Breast Cancer Cells. Adv Pharm Bull. 2023;13(2):317–27.
Lin M, Yao W, Xiao Y, Dong Z, Huang W, Zhang F, et al. Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer. Bioengineered. 2021;12(1):6343–53.
Abrishami A, Bahrami AR, Nekooei S, Sh. Saljooghi A, Matin MM. Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics. Commun Biol. 2024 Dec 1;7(1).
Wang S, Wo L, Zhang Z, Zhu C, Wang C, Wang Y, et al. Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer. Cancer Lett. 2022 Nov 28;549.
Ugalde-Arbizu M, Aguilera-Correa JJ, García-Almodóvar V, Ovejero-Paredes K, Díaz-García D, Esteban J, et al. Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a
Cytotoxic Organotin(IV) Metallodrug. Pharmaceutics. 2023 Feb 1;15(2).
Cunha C, Marinheiro D, Ferreira BJML, Oliveira H, Daniel-da-Silva AL. Morin Hydrate Encapsulation and Release from Mesoporous Silica Nanoparticles for Melanoma Therapy. Molecules. 2023 Jun 1;28(12).
Farjadian F, Faghih Z, Fakhimi M, Iranpour P, Mohammadi-Samani S, Doroudian M. Glucosamine-Modified Mesoporous Silica-Coated Magnetic Nanoparticles: A “Raisin-Cake”-like Structure as an Efficient Theranostic Platform for Targeted Methotrexate Delivery. Pharmaceutics. 2023 Oct 1;15(10).
Lee J, Kim JH, You DG, Kim S, Um W, Jeon J, et al. Cavitation-Inducible Mesoporous Silica–Titania Nanoparticles for Cancer Sonotheranostics. Adv Healthc Mater. 2020 Oct 1;9(19).
Amin MU, Ali S, Ali MY, Tariq I, Nasrullah U, Pinnapreddy SR, et al. Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics. 2021 Aug 1;165:31–40.
Qin G, Xie W, Luo X, Zou G, Mo Q, Zhong W. Manganese-doped stellate mesoporous silica nanoparticles: A bifunctional nanoplatform for enhanced chemodynamic therapy and tumor imaging. Microporous and Mesoporous Materials. 2024 Apr 15;370.
Cordeiro R, Carvalho A, Durães L, Faneca H. Triantennary GalNAc‐Functionalized Multi‐Responsive Mesoporous Silica Nanoparticles for Drug Delivery Targeted at Asialoglycoprotein Receptor. Int J Mol Sci. 2022 Jun 1;23(11).
Almomen A, Alhowyan A. A Comprehensive Study on Folate-Targeted Mesoporous Silica Nanoparticles Loaded with 5-Fluorouracil for the Enhanced Treatment of Gynecological Cancers. J Funct Biomater. 2024 Mar 1;15(3).
dos Apostolos RCR, Andrada A de S, Oliveira AF, Neto ESF, de Sousa EMB. pH-Sensitive Hybrid System Based on Eu3+/Gd3+ Co-Doped Hydroxyapatite and Mesoporous Silica Designed for Theranostic Applications. Polymers (Basel). 2023 Jun 1;15(12).
Guo X, Zhu M, Yuan P, Liu T, Tian R, Bai Y, et al. Supporting Information for Facile formation of hierarchical mesoporous silica nanocarriers for tumor selective multi-model theranostics. 2021.
Estevão BM, Comparetti EJ, Rissi NC, Zucolotto V. Anti-GPC1-modified mesoporous silica nanoparticles as nanocarriers for combination therapy and targeting of PANC-1 cells. Mater Adv. 2021 Aug 7;2(15):5224–35.
Lohiya G, Katti DS. Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy. Carbohydr Polym. 2022 Feb 1;277:118822.
Mishra S, Manna K, Kayal U, Saha M, Chatterjee S, Chandra D, et al. Folic acid-conjugated magnetic mesoporous silica nanoparticles loaded with quercetin: A theranostic approach for cancer management. RSC Adv. 2020 Jun 17;10(39):23148–64.
Ortiz-Islas E, Manríquez-Ramírez ME, Sosa-Muñoz A, Almaguer P, Arias C, Guevara P, et al. Preparation and characterisation of silica-based nanoparticles for cisplatin release on cancer brain cells. IET Nanobiotechnol. 2020 May 1;14(3):191–7.
Refbacks
- There are currently no refbacks.
